-
Carboplatin Workflows for 2D and 3D Cancer Models
2026-09-04
Build more informative Carboplatin response assays by pairing controlled 2D dose–response experiments with 3D spheroid models. This workflow translates proteomic evidence into practical choices for ovarian and lung cancer research while addressing stock preparation, model variability, and combination-study pitfalls.
-
Oligo (dT) 25 Beads: mRNA Purification Guide
2026-09-04
Oligo (dT) 25 Beads selectively capture polyadenylated eukaryotic mRNA from total RNA or eukaryotic cells and tissues for downstream cDNA synthesis, RT-PCR, sequencing, and related applications. They should not be treated as a general total-RNA purification reagent or as a substitute for workflows targeting non-polyadenylated RNA.
-
Cholesterol and Intracellular LNP Trafficking
2026-09-03
A 2025 study developed a sensitive streptavidin–biotin-DNA and high-throughput imaging platform to resolve how lipid nanoparticle composition affects intracellular trafficking. The results identify cholesterol-driven accumulation in peripheral early endosomes as a delivery bottleneck, while showing that DSPC can reduce this adverse trafficking phenotype.
-
Hydroxytyrosol Workflows for Cardiovascular Research
2026-09-03
Build reproducible Hydroxytyrosol assays for oxidative stress modulation, inflammatory phenotyping, and cholesterol efflux. This practical guide translates recent olive-oil polyphenol findings into concentration-controlled workflows, assay controls, and troubleshooting decisions for cardiovascular health research.
-
From mRNA Trafficking to Translational Proof
2026-09-02
A mechanistic and strategic guide to using dual fluorescence–bioluminescence reporters to distinguish mRNA delivery, intracellular trafficking, translation, and immune compatibility in translational research.
-
Tomivosertib Suppresses Human DRG Ectopic Activity
2026-09-02
The reference study provides direct evidence from human dorsal root ganglion neurons that MNK inhibition can rapidly and reversibly suppress spontaneous activity associated with radicular neuropathic pain. Its combination of ex vivo human electrophysiology and eIF4E phosphorylation analysis strengthens the translational rationale for testing MNK inhibitors in neuropathic pain.
-
Catalpol in Osteoporosis Research: A Practical Workflow
2026-09-01
Catalpol, also known as Catalpinoside, offers a mechanism-led workflow for studying osteoclast apoptosis in estrogen-deficiency osteoporosis. This guide translates the reference rat study into practical dosing, cell-based validation, pathway assays, and troubleshooting decisions for reproducible preclinical research.
-
Mitoxantrone Workflows for ABCG2 Resistance
2026-09-01
Mitoxantrone is a practical topoisomerase II probe for apoptosis, multidrug-resistance, and transporter-efflux studies. This workflow shows how to pair controlled DMSO handling with intracellular accumulation and marein-combination assays to distinguish cytotoxicity from ABCG2-mediated resistance.
-
Dabigatran Etexilate: Innovation in Oral Thrombin Inhibition
2026-08-31
The reference review describes dabigatran etexilate as the first oral direct thrombin inhibitor marketed in the United States and explains why its prodrug design addressed important limitations of warfarin and injectable anticoagulants. Its evidence synthesis connects reversible thrombin inhibition, predictable pharmacokinetics, renal considerations, bleeding risk, and clinical efficacy in venous thromboembolism and nonvalvular atrial fibrillation.
-
Oligomycin A for Mitochondrial Energy Assays
2026-08-31
Use Oligomycin A to separate ATP synthase-dependent respiration from glycolytic compensation, mitochondrial ROS, and downstream cell-death phenotypes. This practical workflow connects routine bioenergetic assays with sodium-driven energy failure and metabolic adaptation in cancer while emphasizing controls, dosing logic, and troubleshooting.
-
Streptavidin-Cy3 Workflows for Biohybrid Tumor Studies
2026-08-30
Learn how a streptavidin cy3 conjugate can convert biotinylated antibodies, probes, and particles into measurable signals across IHC, ISH, immunofluorescence, and flow cytometry. This practical guide adapts fluorescence workflows to the deformable, magnetically guided tumor microrobots described in the reference study while emphasizing controls, spectral separation, and reproducibility.
-
Fluorescein TSA Fluorescence System Kit Workflow
2026-08-29
Build a high-sensitivity workflow for rare proteins, transcripts, and signaling states in fixed cells and tissues. This guide connects tyramide signal amplification with diabetic-retina barrier research, while emphasizing assay design, quantitative imaging, and practical troubleshooting.
-
JXE-23 in Hepatocellular Carcinoma: Autophagy and Growth
2026-08-28
The 2024 reference study identifies the fern-derived pimarane diterpene JXE-23 as a selective in vitro inhibitor of HepG2 hepatocellular carcinoma cell growth. Its distinctive finding is that JXE-23 induces protective autophagy alongside G2/M arrest and suppression of the CIP2A/p-AKT/c-Myc signaling axis, suggesting that autophagy inhibition could improve the compound’s anticancer effect.
-
Capecitabine in Patient-Derived Assembloids
2026-08-28
Capecitabine enables a practical comparison of tumor-cell sensitivity with microenvironment-modulated drug response in patient-derived gastric cancer assembloids. This workflow combines prodrug activation biology, matched stromal co-culture, and quantitative viability profiling to support more predictive preclinical oncology research.
-
Saquinavir Workflows for HIV Protease Research
2026-08-27
Build a more informative Saquinavir workflow by pairing HIV protease inhibition with biomimetic membrane-partition measurements. IAM LC offers robust, scalable screening, while LEKC can better represent phospholipid-driven permeability behavior when the compound and assay conditions are compatible.